{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:58:24Z","timestamp":1791644304349,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.amjms.2017.02.004","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T11:03:25Z","timestamp":1487761405000},"page":"433-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus"],"prefix":"10.1016","volume":"353","author":[{"given":"Yaya","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiya","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxing","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.amjms.2017.02.004_bib1","first-page":"221","article-title":"Atherosclerosis: an inflammatory disease","volume":"26","author":"Liuzzo","year":"2001","journal-title":"Rays"},{"issue":"8A","key":"10.1016\/j.amjms.2017.02.004_bib2","doi-asserted-by":"crossref","first-page":"10K","DOI":"10.1016\/S0002-9149(01)01924-5","article-title":"Inflammatory pathways in atherosclerosis and acute coronary syndromes","volume":"88","author":"Plutzky","year":"2001","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.amjms.2017.02.004_bib3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.amjms.2017.02.004_bib4","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1161\/01.CIR.0000013954.65303.C5","article-title":"Prevention conference VI diabetes and cardiovascular disease writing group II: pathogenesis of atherosclerosis in diabetes","volume":"105","author":"Eckel","year":"2002","journal-title":"Circulation"},{"issue":"51","key":"10.1016\/j.amjms.2017.02.004_bib5","doi-asserted-by":"crossref","first-page":"48341","DOI":"10.1074\/jbc.M108395200","article-title":"Endocan is a novel chondroitin sulfate\/dermatan sulfate proteoglycan that promotes hepatocyte growth factor\/scatter factor mitogenic activity","volume":"276","author":"B\u00e9chard","year":"2001","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.amjms.2017.02.004_bib6","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.167.6.3099","article-title":"Human endothelial cell specific molecule-1 binds directly to the integrin CD11a\/ CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1","volume":"167","author":"B\u00e9chard","year":"2001","journal-title":"J Immunol"},{"issue":"21","key":"10.1016\/j.amjms.2017.02.004_bib7","first-page":"A15455","article-title":"Endothelial cell specific molecule-1 (ESM-1), a novel secreted proteoglycan stimulates vascular smooth muscle cell proliferation and migration","volume":"124","author":"Menon","year":"2011","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.amjms.2017.02.004_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0003319714548870","article-title":"Serum endocan level and the severity of coronary artery disease: a Pilot Study","volume":"66","author":"Murat","year":"2015","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.amjms.2017.02.004_bib9","first-page":"1","article-title":"Analysis of serum endothelial cell-specific molecule 1 (Endocan) level in type 2 diabetes mellitus with acute ST-Segment elevation myocardial infarction and its correlation: a pilot study","volume":"67","author":"Qiu","year":"2016","journal-title":"Angiology"},{"issue":"4","key":"10.1016\/j.amjms.2017.02.004_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","article-title":"Prediction of clinical cardiovascular events with carotid intima media thickness: a systematic review and meta-analysis","volume":"115","author":"Lorenz","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.amjms.2017.02.004_bib12","first-page":"328","volume":"14","author":"Perk","year":"2013","journal-title":"G Ital Cardiol (Rome)"},{"issue":"3","key":"10.1016\/j.amjms.2017.02.004_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/0003319715585664","article-title":"Effect of glycemic regulation on endocan levels in patients with diabetes: a preliminary study","volume":"67","author":"Arman","year":"2016","journal-title":"Angiology"},{"issue":"5","key":"10.1016\/j.amjms.2017.02.004_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jcp.24485","article-title":"Endocan elicits severe vascular inflammatory responses in vitro and in vivo","volume":"229","author":"Lee","year":"2014","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.amjms.2017.02.004_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1749-6632.2012.06480.x","article-title":"LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos","volume":"1254","author":"Badimon","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"10.1016\/j.amjms.2017.02.004_bib16","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nm1102-1211","article-title":"Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime","volume":"8","author":"Steinberg","year":"2002","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.amjms.2017.02.004_bib17","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/HJH.0b013e328335043e","article-title":"Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase","volume":"28","author":"Soro-Paavonen","year":"2010","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.amjms.2017.02.004_bib18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","article-title":"Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes","volume":"63","author":"Basta","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.amjms.2017.02.004_bib19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/HYPERTENSIONAHA.110.153056","article-title":"Free fatty acid causes leukocyte activation and resultant endothelial dysfunction through enhanced angiotensin II production in mononuclear and polymorphonuclear cells","volume":"56","author":"Azekoshi","year":"2010","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.amjms.2017.02.004_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.atherosclerosis.2015.07.028","article-title":"SPREDIA-2 group. Carotid atherosclerosis severity in relation to glycemic status: a cross-sectional population study","volume":"242","author":"Mostaza","year":"2015","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.amjms.2017.02.004_bib21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1479164115583192","article-title":"Glycated serum albumin stimulates expression of endothelial cell specific molecule-1 in human umbilical vein endothelial cells: implication in diabetes mediated endothelial dysfunction","volume":"12","author":"Nirala","year":"2015","journal-title":"Diab Vasc Dis Res"},{"issue":"34","key":"10.1016\/j.amjms.2017.02.004_bib22","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1074\/jbc.271.34.20458","article-title":"ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines","volume":"271","author":"Lassalle","year":"1996","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.amjms.2017.02.004_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaad.2013.09.013","article-title":"Serum endocan levels as a marker of disease activity in patients with Behcet\u05f3s disease","volume":"70","author":"Balta","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.amjms.2017.02.004_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/0003319713513492","article-title":"Endocan: a novel inflammatory indicator in newly diagnosed hypertensive patients? A pilot study","volume":"65","author":"Balta","year":"2014","journal-title":"Angiology"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962917301143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962917301143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:24:49Z","timestamp":1536020689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962917301143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0002962917301143"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2017.02.004","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2017.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}